![CorMedix Inc. logo](/logos/CRMD.webp)
CorMedix Inc.
NASDAQ:CRMD
Overview | Financials
Company Name | CorMedix Inc. |
Symbol | CRMD |
Currency | USD |
Price | 5.76 |
Market Cap | 321,753,600 |
Dividend Yield | 0% |
52-week-range | 2.57 - 7 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joseph Todisco MBA |
Website | https://www.cormedix.com |
An error occurred while fetching data.
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD